Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses nutrition in breast cancer, and the role of diabetes and obesity in post-menopausal breast cancer,…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses lateral rectus ligament dysfunction in the eye, its diagnosis and management techniques used…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses eye muscles, which are regulated by connective tissue structures called pulleys, and horizontal…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses new treatment options for depression, particularly deep brain stimulation and injectable treatment…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses migraine diagnosis and diagnostic criteria that focus on associated symptoms…
NEW YORK (Reuters Health) – Intra-partum nevirapine, given to prevent HIV transmission, contributes to HIV resistance mutations to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) – but a one-month postpartum course…
NEW YORK (Reuters Health) – Researchers cut short a clinical trial of the endothelin blocker avosentan in patients with diabetic nephropathy because it was linked with fluid overload…
NEW YORK (Reuters Health) – Intravenous vitamin C before elective percutaneous coronary intervention (PCI) improves microcirculatory reperfusion, new research shows. This suggests oxidative stress is to blame for…
NEW YORK (Reuters Health) – In patients with complex multivessel coronary disease, long-term revascularization rates are lower after surgery than after percutaneous coronary intervention (PCI) with sirolimus-eluting stents,…
